Gritstone bio (GRTS) stock forecast for 2027
Last update: November 29, 2023 (08:09)
Sector: HealthcareThe share price of Gritstone bio, Inc. (GRTS) now
50/200 Day Moving Average: $1.789 / $2.112
This figure corresponds to the Average Price over the previous 50/200 days. For Gritstone bio stocks, the 50-day moving average is the resistance level today.
For Gritstone bio stocks, the 200-day moving average is the resistance level today.
Are you interested in Gritstone bio stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Gritstone bio stock price in 2027. How much will one Gritstone bio share be worth in 2027? Is it worth taking profit / loss on Gritstone bio stock now or waiting? What are analysts' forecasts for Gritstone bio stock?
We forecast Gritstone bio stock performance using neural networks based on historical data on Gritstone bio stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. The Gritstone bio stock prediction results are shown below and presented as a graph, table and text information.
Gritstone bio stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Gritstone bio analysts is $10.4.
Today 200 Day Moving Average is the resistance level (2.112 $).
50 Day Moving Average is the support level (1.789 $).
Historical and forecast chart of Gritstone bio stock
The chart below shows the historical price of Gritstone bio stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Gritstone bio stock price can be found in the table below.
Gritstone bio (GRTS) Forecast for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 2.59 | 2.28 | 2.78 | 17.91 % |
| Mar | 2.85 | 2.53 | 2.94 | 14.11 % |
| Mar | 2.94 | 2.70 | 3.18 | 14.94 % |
| Apr | 3.08 | 2.92 | 3.47 | 15.79 % |
| May | 3.21 | 3.07 | 3.44 | 10.90 % |
| Jun | 2.96 | 2.69 | 3.23 | 16.74 % |
| Jul | 2.78 | 2.61 | 2.91 | 10.12 % |
| Aug | 3.17 | 2.85 | 3.41 | 16.34 % |
| Sep | 3.06 | 2.78 | 3.32 | 16.10 % |
| Oct | 3.50 | 3.36 | 3.72 | 9.50 % |
| Nov | 3.26 | 2.95 | 3.55 | 16.86 % |
| Dec | 3.54 | 3.25 | 3.74 | 13.18 % |
Gritstone bio information and performance
Gritstone Oncology, Inc., an immuno-oncology company, is developing tumor-specific immunotherapeutic agents to combat various types of cancer. The leading product candidate is GRANIT, which is in phase I clinical trials for the treatment of solid tumors, including metastatic non-small cell lung cancer, gastroesophageal, urinary and microsatellite stable, and colorectal cancers.
5858 HORTON STREET, SUITE 210, EMERYVILLE, CA, US
Market capitalization of the Gritstone bio, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of GRTS shares in the company outstanding by the market price of one share.
EBITDA of Gritstone bio is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Gritstone bio price target for 2027 by month
Target values for the price of one Gritstone bio share for Jan 2027.
In Jan, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 17.910% volatility is expected.
Pessimistic target level: 2.28
Optimistic target level: 2.78
Target values for the price of one Gritstone bio share for Mar 2027.
In Mar, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 14.109% volatility is expected.
Pessimistic target level: 2.53
Optimistic target level: 2.94
Target values for the price of one Gritstone bio share for Mar 2027.
In Mar, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 14.941% volatility is expected.
Pessimistic target level: 2.70
Optimistic target level: 3.18
Target values for the price of one Gritstone bio share for Apr 2027.
In Apr, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 15.790% volatility is expected.
Pessimistic target level: 2.92
Optimistic target level: 3.47
Target values for the price of one Gritstone bio share for May 2027.
In May, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 10.896% volatility is expected.
Pessimistic target level: 3.07
Optimistic target level: 3.44
Target values for the price of one Gritstone bio share for Jun 2027.
In Jun, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 16.740% volatility is expected.
Pessimistic target level: 2.69
Optimistic target level: 3.23
Target values for the price of one Gritstone bio share for Jul 2027.
In Jul, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 10.122% volatility is expected.
Pessimistic target level: 2.61
Optimistic target level: 2.91
Target values for the price of one Gritstone bio share for Aug 2027.
In Aug, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 16.345% volatility is expected.
Pessimistic target level: 2.85
Optimistic target level: 3.41
Target values for the price of one Gritstone bio share for Sep 2027.
In Sep, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 16.100% volatility is expected.
Pessimistic target level: 2.78
Optimistic target level: 3.32
Target values for the price of one Gritstone bio share for Oct 2027.
In Oct, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 9.502% volatility is expected.
Pessimistic target level: 3.36
Optimistic target level: 3.72
Target values for the price of one Gritstone bio share for Nov 2027.
In Nov, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 16.862% volatility is expected.
Pessimistic target level: 2.95
Optimistic target level: 3.55
Target values for the price of one Gritstone bio share for Dec 2027.
In Dec, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 13.182% volatility is expected.
Pessimistic target level: 3.25
Optimistic target level: 3.74
